Abano sees opportunities in Australia and NZ


"Consolidation activity in the dental sector in Australia is ongoing. Abano has received various expressions of interest, which may offer strategic opportunities and value to shareholders," it said in a statement.

The group said that it had "paused acquisitions in Australia", given current Australian acquisition multiples and trading conditions. It said that capital will be invested in New Zealand acquisitions to grow the existing Lumino network.

At the same time the group confirmed guidance for the year. Full year results to the end of May should see EBITDA of NZ$32.7m (US$22m) with NPAT of NZ$10.1m.

Abano shares slumped 32% at the end of March after it downgraded its earnings outlook, but have recovered since then. They closed the day up 17.85% at NZ$4.16.



Do you have some news or a press release that you’d like to share with the medical travel industry?

Publish for FREE on IMTJ.


Related News

Croatia inbound medical travel plans

27 May, 2020

Plan for renewing dental travel to Croatia

Turkey re-opens medical tourism

19 May, 2020

Inbound foreign patients to Turkey from 20 May

Qatar private healthcare

13 May, 2020

Non-emergency medical services in Qatar remain suspended

Switzerland re-opens slowly

30 April, 2020

Restrictions easing in Switzerland

More UK outbound dental travel?

30 April, 2020

UK private dental market close to collapse